Trial
NCT00832338
Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
Sanofi
Condition
Breast Neoplasms
Intervention
Docetaxel with Cytoxan
Why stopped
Funding withdrawn
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-31